Stock 688302 HINOVA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Hinova Pharmaceuticals Inc.

Equities

688302

CNE1000059F5

End-of-day quote Shanghai S.E.
Other stock markets
 18:00:00 2024-06-20 EDT 		5-day change 1st Jan Change
27.05 CNY +0.04% Intraday chart for Hinova Pharmaceuticals Inc. -4.48% -48.05%
04-26 Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 China Stocks Fall Ahead of March Economic Data Release MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
China Stocks Fall Ahead of March Economic Data Release
MT
Hinova Pharma Gets Nod to Trial HP501 Tablets; Shares Down 3%
MT
China Healthcare Stocks Rally on Hopes for Government Support
DJ
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hinova Pharmaceuticals Gets Nod to Trial HP537 Tablets
MT
Hinova Pharmaceuticals Gets Nod to Test Prostate Cancer Drug
MT
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Hinova Pharmaceuticals to Resubmit Application for Deuterated Enzalutamide Soft Capsules
MT
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Hinova Pharma Gets Regulatory Nod for Anti-Tumor Drug Trial
MT
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment
CI
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit
CI
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Hinova Pharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688302 Stock
  4. News Hinova Pharmaceuticals Inc.
  5. Highlights